Offer - Urjas Oil for just ₹ 1
Dilsave 4 Tablet is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Atrial Fibrillation.
The correct dosage of Dilsave 4 Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Dilsave 4 Tablet include Fatigue. Apart from the aforementioned side effects, Dilsave 4 Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Dilsave 4 Tablet go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Dilsave 4 Tablet is Severe for pregnant women and Severe for women who are breastfeeding. Further, the section on Dilsave 4 Tablet related warnings talks about Dilsave 4 Tablet's effects on the liver, heart and kidney.
Dilsave 4 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Heart Disease, Liver Disease are examples of such conditions. Other contraindications of Dilsave 4 Tablet have been discussed in the sections ahead.
Additionally, Dilsave 4 Tablet may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Dilsave 4 Tablet, it is important to know that it is safe while driving, and is habit-forming.
Dilsave 4 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Dilsave 4 Tablet safe for pregnant women?
Dilsave should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Dilsave 4 Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Dilsave. So it is adviced to consult the doctor before using it.
What is the effect of Dilsave 4 Tablet on the Kidneys?
Using Dilsave does not have any harmful effects on kidneys.
What is the effect of Dilsave 4 Tablet on the Liver?
Side effects of Dilsave rarely affect the liver.
What is the effect of Dilsave 4 Tablet on the Heart?
Side effects of Dilsave rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Dilsave 4 Tablet unless your doctor advises you to do so -
Is this Dilsave 4 Tablet habit forming or addictive?
Forming a habit of Dilsave 4 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Dilsave 4 Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, Dilsave 4 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Dilsave 4 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Dilsave 4 Tablet
Taking certain foods and Dilsave 4 Tablet together may have severe side effects. Talk to your doctor about it.
Interaction between Alcohol and Dilsave 4 Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Dilsave 4 Tablet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Multaq (dronedarone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 534
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 470-472